Prospects for TIM3-Targeted Antitumor Immunotherapy. [electronic resource]
Producer: 20120109Description: 6567-71 p. digitalISSN:- 1538-7445
- Animals
- Antibodies, Monoclonal -- immunology
- Antigen-Presenting Cells -- immunology
- CTLA-4 Antigen -- antagonists & inhibitors
- Clonal Anergy -- immunology
- Combined Modality Therapy
- Drug Screening Assays, Antitumor
- Drug Synergism
- Forecasting
- Hepatitis A Virus Cellular Receptor 2
- Humans
- Immunologic Memory -- immunology
- Immunotherapy -- methods
- Lymphocyte Activation -- immunology
- Lymphocytes, Tumor-Infiltrating -- immunology
- Membrane Proteins -- antagonists & inhibitors
- Mice
- Molecular Targeted Therapy
- Neoplasm Proteins -- antagonists & inhibitors
- Neoplasms -- immunology
- Neoplasms, Experimental -- immunology
- Receptors, Virus -- antagonists & inhibitors
- T-Lymphocyte Subsets -- immunology
- Tumor Microenvironment -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.